Fighting brain tumors with the help of viruses and molecules
By harnessing unusual allies, pioneering cancer treatments could reduce the need for invasive surgery and save lives.
Dec 19, 2023
0
1
By harnessing unusual allies, pioneering cancer treatments could reduce the need for invasive surgery and save lives.
Dec 19, 2023
0
1
Scientists at LSU Health New Orleans' Neuroscience Center of Excellence, led by Nicolas Bazan, MD, Ph.D., Boyd Professor and Director, have identified a new mechanism that regulates a protein key for cell survival. It appears ...
Dec 18, 2023
0
51
Immunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastatic breast cancer. Which patients will benefit the most, however, remains unclear; current biomarkers ...
Dec 14, 2023
0
0
The targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival (PFS) and achieved an overall remission rate in 82% of patients with relapsed/refractory mantle cell lymphoma (MCL), ...
Dec 12, 2023
0
0
CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities.
Dec 11, 2023
0
10
New research in the December 2023 issue of Journal of the National Comprehensive Cancer Network finds that patients treated with first-line immunotherapy for advanced non-small cell lung cancer (NSCLC) showed similar results ...
Dec 11, 2023
0
0
Men with hormone-resistant prostate cancer and specific genetic mutations who were treated with the PARP inhibitor drug olaparib survived longer than men treated with traditional hormone therapy, according to an analysis ...
Dec 7, 2023
0
1
A collaboration between researchers from Cornell and University of Alberta, Edmonton, has created a new technique to treat type 1 diabetes: implanting a device inside a pocket under the skin that can secrete insulin while ...
Dec 5, 2023
0
46
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer ...
Dec 4, 2023
0
53
Immunotherapy using modified chimeric antigen receptor (CAR) T cells has greatly improved survival rates for pediatric patients with relapsed and recurrent leukemia. However, these therapies are not as effective in treating ...
Nov 30, 2023
0
15